Savara (SVRA) Common Equity (2010 - 2026)
Savara (SVRA) recorded Common Equity of $143.66 million in Q2 2026, up 19.2% from $120.48 million a year earlier but down 18.4% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Savara reported Common Equity of $203.13 million, up 18.5% from FY2024.
- Annual Common Equity has increased for three straight years, with a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $171.45 million in FY2024 (+22.1%), $140.37 million in FY2023 (+30.2%), $107.78 million in FY2022 (-25.4%) and $144.5 million in FY2021 (+124.4%).
- Quarterly Common Equity has ranged from $87.72 million in Q2 2023 to $203.13 million in Q4 2025 over the past five years.
- On a year-over-year basis, Common Equity has increased for three consecutive quarters, with growth averaging 12.8% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 124.4% in Q4 2021, against a decline of 52.7% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $176.04 million (Q1 2026), $203.13 million (Q4 2025) and $94.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Savara | 1.04 Bn | 1.04 Bn | - | 143.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.66 Mn |
| Mar 31, 2026 | 176.04 Mn |
| Dec 31, 2025 | 203.13 Mn |
| Sep 30, 2025 | 94.39 Mn |
| Jun 30, 2025 | 120.48 Mn |
| Mar 31, 2025 | 147.85 Mn |
| Dec 31, 2024 | 171.45 Mn |
| Sep 30, 2024 | 199.35 Mn |
| Jun 30, 2024 | 101.73 Mn |
| Mar 31, 2024 | 121.86 Mn |
| Dec 31, 2023 | 140.37 Mn |
| Sep 30, 2023 | 146.54 Mn |
| Jun 30, 2023 | 87.72 Mn |
| Mar 31, 2023 | 98.26 Mn |
| Dec 31, 2022 | 107.78 Mn |
| Sep 30, 2022 | 116.51 Mn |
| Jun 30, 2022 | 127.04 Mn |
| Mar 31, 2022 | 136.48 Mn |
| Dec 31, 2021 | 144.50 Mn |
| Sep 30, 2021 | 155.23 Mn |
API Access
Savara Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();